News

APN311 is a monoclonal chimeric antibody developed to treat neuroblastoma, a malignant tumor developing from nerve tissue and most common in children below five years. Paladin Labs interim

Xencor has received an undisclosed amount as the milestone payment from Janssen for the use of Xtend antibody technology platform. Xencor president and CEO Bassil Dahiyat said, "There

Prism is an electronic data capture (EDC) solution, which is designed to streamline the initiation and management of clinical trials. During the Connectathon demonstration, Prism will facilitate live

Under the collaboration, Mobile MedSoft’s Helix Pharmacy System customers will now gain access to Mevesi’s software to analyze the data and gain a better understanding of their business.

The throat and nasal spray is produced using a combination of natural ingredients such as elderberry, eucalyptus and mint blended in a number of layers. Spray mechanism will

The extraction service will complement the company’s existing capacity in Berlin, Germany and London, UK and will be delivered from the genomics laboratory in Beverly, Massachusetts , US.

The company anticipates making the hypertension medication, that is to be administered once a day, available to patients across Canada in the second quarter of 2013. Forest Laboratories

Both the companies plan to integrate the management of Daiichi Sankyo (Thailand) (DSTH) and Ranbaxy Unichem (RUCL), the Thailand subsidiary of Daiichi Sankyo and Ranbaxy’s Thailand subsidiary respectively.

The submissions for the approval are supported by risk stratification data and a risk algorithm, which enables physicians and patients with MS to make informed decisions when considering